The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after identifying a safety concern.

The Food and Drug Administration halted Novavax's trial of a combination vaccine for COVID and influenza, as well as a standalone flu shot, after a participant suffered a serious adverse event ...

The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after one person who received the shot reported nerve damage, the company ...

FDA places a clinical hold on Novavax's COVID-19-influenza vaccine trials due to a serious adverse event in a Phase 2 participant. Novavax's COVID-19 IND and European approval for its updated ...

The U.S. Food and Drug Administration has put a trial of Novavax’s COVID-influenza and its standalone flu vaccines on hold after a participant who took the combination shot reported nerve damage ...

Shares of Novavax (NASDAQ:NVAX) fell roughly 30% Wednesday morning after the U.S. FDA put a clinical hold on the new drug application of its COVID-19 and influenza combination vaccine and ...

That deal saw Novavax retain the rights to its combo COVID-flu vaccine, while Sanofi has the sole license to use Novavax’s adjuvanted COVID-19 vaccine in combination with Sanofi's own flu vaccines.

Novavax can move forward with a trial for its combined Covid-19 and influenza vaccine after regulators lifted a clinical hold. The Gaithersburg, Md., vaccine developer said Monday that the U.S ...

The U.S. Food and Drug Administration has put on hold a trial of Novavax's COVID-influenza and its standalone flu vaccines after a participant who took the combination shot reported nerve damage ...

Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials Nov. 11, 2024 9:18 AM ET Novavax, Inc. (NVAX) Stock By: Preeti Singh , SA News Editor 2 Comments Play ( 1min ) ...